Risk of repeated Moraxella catarrhalis colonization is increased in children with Toll-like receptor 4 Asp299Gly

Juho Vuononvirta1, Ville Peltola, Jussi Mertsola

  • 1From the *Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare; †Department of Pediatric, Turku University Hospital; and ‡Turku Institute for Child and Youth Research, University of Turku, Turku, Finland.

Abstract

Insights

Finnish children with the Toll-like receptor (TLR) 4 Asp299Gly gene variant show a significantly higher risk of repeated Moraxella catarrhalis colonization. This genetic variation impacts innate immunity, increasing susceptibility to this common respiratory pathogen.

Area of Science:

  • Immunology
  • Pediatrics
  • Microbiology

Background:

  • Moraxella catarrhalis is a frequent cause of pediatric respiratory infections, including acute otitis media.
  • Toll-like receptor (TLR) 4 plays a crucial role in the human innate immune response.
  • The TLR4 Asp299Gly polymorphism is associated with a diminished response to Gram-negative bacterial lipopolysaccharides.

Purpose of the Study:

  • To investigate the association between the TLR4 Asp299Gly polymorphism and the risk of M. catarrhalis colonization in young Finnish children.
  • To determine if carrying the TLR4 Asp299Gly variant increases susceptibility to M. catarrhalis during the first two years of life.

Main Methods:

  • A prospective cohort study was conducted in Turku, Finland, involving 161 children.
  • Nasopharyngeal specimens were collected at 2, 12, and 24 months of age.
  • Bacterial identification used semiquantitative culture, and TLR4 Asp299Gly detection utilized pyrosequencing.

Main Results:

  • The prevalence of M. catarrhalis increased with age, reaching 58% by 24 months.
  • Children with the TLR4 Asp299Gly variant (22% of subjects) had a 4.91-fold increased risk of M. catarrhalis colonization at all three time points compared to wild-type.
  • Subjects with the TLR4 variant exhibited significantly higher nasopharyngeal bacterial loads of M. catarrhalis.

Conclusions:

  • The TLR4 Asp299Gly polymorphism is linked to an elevated risk of persistent M. catarrhalis colonization in children.
  • This genetic predisposition may impact the course of common childhood respiratory infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
197
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
251